Because GLP-1 pricing now varies by drug, dose, formulation, and whether a patient is in an introductory or maintenance phase, its helpful to consider a range of current prices
When to reassess: If you havent lost 5% of starting weight by 1216 weeks at maintenance dose, most guidelines recommend stopping and considering alternatives (Pharmacy & Therapeutics, 2016
Long-lasting Satisfaction : The combination of GLP-1 release and proteins natural satiety effects helps reduce cravings and between-meal hunger
Stay Hydrated So simple, so important, but so often overlooked
And that came from a recent trial that was published in the New England Journal of Medicine
Regarding lack of access to the Bridge Program, we want to clarify the following: Under federal law, Medicare Part D plans cannot cover medications prescribed for weight loss Medications that are FDA-approved for both weight loss and other indications may only be covered by Part D plans for non-weight loss indications. This Bridge Program is a trial of a way to address the particular problem of Part D restrictions on weight-loss prescriptions
